Vaccine development against cutaneous leishmaniasis. Subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge.

Source:http://linkedlifedata.com/resource/pubmed/id/8446467

Download in:

View as

General Info

PMID
8446467